In the field of rare diseases the AOP Orphan team develops and investigates therapy options for patients with rare diseases – commitment and appreciation are the essence of our cooperative work.
"As an agile international team we strive for ambitious goals. This requires alignment across countries and functions as well as each one of us feeling accountable for the end result. Together we make a difference, and AOP Orphan a great place to work."
"AOP Orphan is the European pioneer in Orphan Diseases unconditionally committed to bringing not only drugs but full treatment support to patients with rare diseases."
"As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care."
"AOP Orphan having international expertise in pharmaceutical and clinical development as well as distribution and marketing of drugs in the rare disease area offers flexible solutions for in- and out-licensing partnerships."
"Every day we at AOP Orphan consolidate our knowledge, expertise and energy to ensure that the patients get necessary treatments available notwithstanding the market complexity and challenges."
"AOP Orphan has successfully developed a number of innovative treatment options in recent years. To arrive at these, our thinking is guided above all by patient needs."
"To provide patients with effective drugs COLLABORATION is the key for success- within and between pharmaceutical industry and academia."
"Imagine you find a solution to a complex rare disease and can make this available to afflicted people."
"What drives me are the highly individual needs of patients and physicians. We try to predict these, understand them and, as a consequence, act in a rapid, professional and empathic way."
"Finding solutions for apparently impossible tasks, always focusing on the patients with a deep appreciation of their disease experience makes AOP Orphan a unique partner."